A comparison between PLGA-PEG and NIPAAm-MAA nanocarriers in curcumin delivery for hTERT silencing in lung cancer cell line
- PMID: 27585262
A comparison between PLGA-PEG and NIPAAm-MAA nanocarriers in curcumin delivery for hTERT silencing in lung cancer cell line
Abstract
Lung cancer is the most common cancer among men. Since the main reason of cancer cells immortality is telomerase activity, targeting of such enzyme can be a promising approach in cancer therapy. Curcumin is a safe and efficient anticancer agent in this context, but its applications in cancer therapy are limited because of its hydrophobic structure and low solubility in water. Today, using nanocarriers for delivery of such anticancer agents is a well performed method. Here, we developed and compared the efficiency of two nanocarriers (PLGA-PEG and NIPAAm-MAA) in delivery of curcumin and also in levels of hTERT silencing in lung cancer cell line (calu-6). Scanning electron microscopy, MTT assays and real-time PCR were used for imaging, cytotoxicity testing and measuring the expression levels of hTERT after treatment of cells with different concentrations of free curcumin and curcumin loaded nanocarriers. The MTT results demonstrated that the IC50 values of curcumin loaded nanocarriers were in lower concentrations than free curcumin. The hTERT expression levels were decreased by curcumin loaded PLGA-PEG more than curcumin loaded NIPAAm-MAA and free curcumin. Our results showed that the curcumin loaded PLGA-PEG can be a useful nano based carrier for delivery of anti-cancer agents such as curcumin to fight lung cancer.
Similar articles
-
The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells.Anticancer Agents Med Chem. 2017;17(10):1363-1373. doi: 10.2174/1871520617666170213115756. Anticancer Agents Med Chem. 2017. PMID: 28270067
-
PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells.Artif Cells Nanomed Biotechnol. 2016;44(2):735-42. doi: 10.3109/21691401.2014.982803. Epub 2015 Mar 30. Artif Cells Nanomed Biotechnol. 2016. PMID: 25819738
-
Comparison between effects of free curcumin and curcumin loaded NIPAAm-MAA nanoparticles on telomerase and PinX1 gene expression in lung cancer cells.Asian Pac J Cancer Prev. 2014;15(20):8931-6. doi: 10.7314/apjcp.2014.15.20.8931. Asian Pac J Cancer Prev. 2014. PMID: 25374231
-
Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.J Pharm Pharmacol. 2016 Dec;68(12):1481-1500. doi: 10.1111/jphp.12611. Epub 2016 Oct 17. J Pharm Pharmacol. 2016. PMID: 27747859 Review.
-
Curcumin Delivery Mediated by Bio-Based Nanoparticles: A Review.Molecules. 2020 Feb 6;25(3):689. doi: 10.3390/molecules25030689. Molecules. 2020. PMID: 32041140 Free PMC article. Review.
Cited by
-
Therapeutic applications of curcumin nanomedicine formulations in cystic fibrosis.Prog Biomater. 2022 Dec;11(4):321-329. doi: 10.1007/s40204-022-00198-3. Epub 2022 Jul 29. Prog Biomater. 2022. PMID: 35904711 Free PMC article. Review.
-
Cisplatin-based Liposomal Nanocarriers for Drug Delivery in Lung Cancer Therapy: Recent Progress and Future Outlooks.Curr Pharm Des. 2024;30(36):2850-2881. doi: 10.2174/0113816128304923240704113319. Curr Pharm Des. 2024. PMID: 39051580 Review.
-
Casticin Induces DNA Damage and Affects DNA Repair Associated Protein Expression in Human Lung Cancer A549 Cells (Running Title: Casticin Induces DNA Damage in Lung Cancer Cells).Molecules. 2020 Jan 15;25(2):341. doi: 10.3390/molecules25020341. Molecules. 2020. PMID: 31952105 Free PMC article.